Phase II study of hexamethylmelamine in women with advanced breast cancer refractory to standard cytotoxic therapy

J. M. Denefrio, C. L. Vogel

Research output: Contribution to journalArticle

10 Scopus citations

Abstract

In the present dose and schedule, the authors found hexamethylmelamine to be ineffective in the management of metastatic breast cancer already refractory to standard chemotherapy and hormonal therapeutic approaches in 19 cases.

Original languageEnglish (US)
Pages (from-to)173-175
Number of pages3
JournalCancer Treatment Reports
Volume62
Issue number1
StatePublished - Jan 1 1978

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Phase II study of hexamethylmelamine in women with advanced breast cancer refractory to standard cytotoxic therapy'. Together they form a unique fingerprint.

  • Cite this